Neuroendocrine Carcinoma Treatment Market Role of Artificial Intelligence and Data Analytics
The neuroendocrine carcinoma treatment market is set for robust growth over the next decade. Global revenue is projected at USD 1,976 million in 2024 and is forecast to reach USD 4,305.7 million by 2034, expanding at a steady CAGR of 8.1%. Rising cancer awareness, continuous research investments, and technological advances in treatment methods are driving this transformation.
Key Growth...